BOMI Group collaborates with Veratrak to streamline operations and provide clients with easier integration. Veratrak has announced its collaboration with BOMI Group as they join the Veratrak-led Integrated Warehouse Project. The company has joined the Integrated Warehouse Project to leverage the industry-wide collaboration platform and move away from peer-to-peer (P2P) messaging between pharmaceutical companies and logistics partners. BOMI Group will benefit from Veratrak by connecting to the Integrated Warehouse Hub to reach sustainability goals, optimize supply chain operations and facilitate better data transfer between it and its HLS partners. The Integrated Warehouse is a cloud-based hub, backed by blockchain technology and is the first ever HLS-LSP decentralized data exchange platform. Blockchain technology will be used at participating organizations to verify data coming into the Integrated Warehouse message hub, thereby creating a single and irrefutable source of truth for all messages that are shared between Healthcare & Life Sciences (HLS) companies and Logistics Service Providers (LSPs). CEO of Veratrak, Jason Lacombe comments: “We are thrilled to welcome BOMI Group…
Skyepharma will leverage the platform to exchange and collaborate on quality and manufacturing records with its supply chain partners. Skyepharma, a French contract development and manufacturing organisation (CDMO), has selected the Veratrak platform to ensure data integrity and enable secure data sharing throughout its supply chain. Using Veratrak, Skyepharma will leverage the platform to exchange and collaborate on quality and manufacturing records with its supply chain partners. This means that Skyepharma now has the ability to streamline the onboarding of new customers and securely exchange manufacturing, quality, and analytical data. It will also enable Skyepharma to have complete data integrity to store and share data securely throughout its operations and those of its supply chain partners. Skyepharma is working with international clients, which require the highest degree of data security, and Veratrak helps the CDMO meet these expectations. Commenting on the partnership, Veratrak CEO, Jason Lacombe said: “We are delighted to welcome Skyepharma to the Veratrak platform. We’re looking forward to helping the company and its partners benefit…
We were delighted to be part of the Oxford Saïd Entrepreneurship Forum at the Oxford Saïd Business School. On 3rd March 2018, the Veratrak leadership team attended OSEF, a forum for entrepreneurship in Oxford. The day featured a wide range of interesting topics, from interviews with successful serial entrepreneurs, discussions on HealthTech and the funding landscape in Europe. The day concluded with a series of talks from companies using innovative approaches. Veratrak CEO Jason Lacombe, spoke as part of this. He presented attendees with a frank look at issues faced in the pharmaceutical supply chain with security and collaboration. He then spoke about how Veratrak is solving those problems for our customers. Jason Presenting to Crowd at OSEF It was great to be involved in the Oxford Saïd Entrepreneurship Forum..
As part of a joint event between the Oxford Foundry and the Oxford University Blockchain Society, Veratrak CEO, Jason Lacombe discussed with fellow experts "How Blockchain Will Radically Change our Society". The event was billed as "an evening conversation about what Blockchain is capable of doing, and how it will transform business, work, governance and society." and Jason was involved in some in depth discussion with the other experts on the panel. The panel comprised of: Jack Laing, Oxford University Blockchain Society President (Chair)Ludwig Siegele, Technology Editor at The EconomistRuth Milligan, Head of Financial Services & Payments Programme at Tech UKJason Lacombe, CEO at VeratrakProfessor Vili Lehdonvirta, Associate Professor and Senior Research Fellow at the Oxford Internet Institute Discussion topics ranged from Decentralised Autonomous Organisations (DAOs), to the implications of immutability for data privacy. The panel was followed by a networking session with many more questions and interesting discussion on how Veratrak is practically solving problems within the pharmaceutical supply chain. Audience at Oxford Foundry Panel
In a detailed landscape analysis examining the UK blockchain ecosystem both Veratrak and CEO, Jason Lacombe, were identified as key influencers. The report was led by the All Party Parliamentary Group on Blockchain, as well as, the Big Innovation Centre, Deep Knowledge Analytics, and DAG Global. The report highlights that the UK is increasingly being viewed on a global scale as a hub for blockchain activities, and investments in UK-backed blockchain companies continues to rise. At Veratrak, we are thrilled to be featured in this report which presents an in-depth analysis of 225 companies, 180 investors and 30 tech hubs and is the most robust analysis of the UK blockchain ecosystem to date.
We were thrilled to be invited to talk at Pharmapack Europe 2018 about what Veratrak is doing to drive innovation in the pharmaceutical supply chain. On 7th February 2018, Veratrak CEO Jason Lacombe, spoke to conference attendees about issues faced with security and collaboration with supply chain partners, educated attendees on the huge benefits that blockchain technology can bring to this problem, and spoke about our pilot projects and vision.
Veratrak is honoured to have won the prestigious Oxford University "Innovation of the Year" Award. This annual competition highlights the best and most promising of the University's innovative businesses. The award consists of a significant cash prize, follow-on investment opportunities, and ongoing mentorship from some members of the expert judging panel. Facing stiff competition from over 30 Oxford based companies, Veratrak was selected as the winner by an expert panel including Gerald Chan. Veratrak presenting to the crowd at the tri-innovate event.
From Tuesday October 9th - Thursday October 11th members of the Veratrak team were in attendance at CPHI in Madrid. This annual global conference is the largest gathering of pharmaceutical professionals in the world, and attended by over 45,000 industry people and 2,500 companies exhibiting. It was great to have the opportunity to speak with so many companies, and understand the ways in which they collaborate on documentation. We are excited to continue to work with, and explore opportunities with these companies.
Veratrak is excited to announce that they are a founding member of the European Platform on Changing Healthcare (EPOCH). This is the First European Blockchain Working Group for the Pharmaceutical Industry. EPOCH is an industry-specific technology working group that brings together pharmaceutical supply chain executives, emerging technologies thought leaders, standards agencies and 3rd party consultants/innovation groups. With interactive collaboration, the platform aims to: create dialogue about the future of the industry for adopting innovative technologies, produce industry papers outlining recommendations and a roadmap to adopting a more lean and secure pharmaceutical supply chain, and educate about the capabilities of blockchain using a pragmatic and hypothesis-driven approach.To learn more and become a member visit www.epoch-group.org or follow EPOCH on Twitter @theEPOCHgroup.
We were honoured to take part in a Silicon Valley Healthcare Innovation Day hosted by Plug and Play in Sunnyvale California. It was great to have the opportunity to speak to a wide variety of healthcare innovators, and to take inspiration from the other companies presenting. https://www.youtube.com/embed/K1OBJV72YbI